VERVE THERAPEUTICS H-1B Visa Sponsorship & Salary Data

The median H-1B salary at VERVE THERAPEUTICS is $100,797, based on 24 certified filings from FY 2020 to FY 2025. This is 16% lower than the national H-1B median salary of $120,000. Compensation at VERVE THERAPEUTICS reflects their market positioning, with entry-level roles starting around $90,000 and senior positions reaching $140,000 or higher. These figures represent base salaries in LCA filings and may not include bonuses, equity grants, or other compensation common at large employers.

Salaries at VERVE THERAPEUTICS range from $82,846 at the 10th percentile to $140,000 at the 90th percentile, showing a $57,154 spread across experience levels and roles. The 25th percentile is $90,000 and the 75th percentile is $126,610.

Yes, VERVE THERAPEUTICS actively sponsors H-1B visas in FY 2025. In the most recent fiscal year (FY 2025), VERVE THERAPEUTICS filed 5 H-1B labor condition applications with 4 certified and 0 denied, at a median salary of $140,795. Across FY 2020–2025, they have filed 27 total H-1B applications with 24 certified and a 7.4% lifetime denial rate, demonstrating ongoing commitment to hiring international talent. VERVE THERAPEUTICS sponsors positions across multiple job categories and locations, making them a viable option for professionals seeking H-1B visa sponsorship.

In the most recent fiscal year (FY 2025), VERVE THERAPEUTICS filed 5 H-1B applications, with 4 certified and 0 denied. Over 6 years of data, VERVE THERAPEUTICS has consistently demonstrated commitment to H-1B sponsorship.

Note: These are Labor Condition Applications (LCAs) filed with the Department of Labor, which is a prerequisite for H-1B petitions. The actual number of H-1B petitions filed with USCIS may differ.

VERVE THERAPEUTICS's LCA (Labor Condition Application) denial rate is 7.4%, with 2 out of 27 applications denied across all years. This translates to a 92.6% certification rate, which indicates how successfully the company prepares and files H-1B applications. A lower denial rate suggests better compliance with Department of Labor requirements, proper wage documentation, and accurate job classification. Prospective H-1B applicants should consider this approval rate alongside other factors like salary, job role, and location when evaluating VERVE THERAPEUTICS as a potential H-1B sponsor.

This denial rate is higher than average. Applicants should ensure all documentation is thoroughly prepared and work closely with VERVE THERAPEUTICS's immigration team.

VERVE THERAPEUTICS sponsors H-1B visas for various specialty occupation positions requiring at least a bachelor's degree. Based on 24 certified filings, the most commonly sponsored job titles reflect the company's primary business functions and talent needs. These positions typically require specialized knowledge in fields like technology, engineering, finance, or scientific research. Understanding which roles VERVE THERAPEUTICS most frequently sponsors can help job seekers target their applications effectively.

Most common H-1B job titles at VERVE THERAPEUTICS:

The most frequently sponsored role is Associate Research Scientist with 7 filings at a median salary of $94,000. This is followed by Research Scientist (4 filings) and Research Scientist II.

VERVE THERAPEUTICS's H-1B positions are distributed across multiple U.S. locations, with concentration in major metropolitan areas and tech hubs. Geographic distribution often reflects company office locations, client sites, and regional market demands. Location significantly impacts H-1B salary due to varying cost of living and local wage requirements. Understanding where VERVE THERAPEUTICS sponsors H-1B workers can help candidates target specific offices and negotiate appropriate compensation for each market.

Top VERVE THERAPEUTICS H-1B locations:

The largest H-1B hub for VERVE THERAPEUTICS is Boston, MA with 18 filings at a median salary of $108,410. The highest-paying location is Somerville, MA at $140,795 median. Salaries range from $90,000 to $140,795 across office locations.

VERVE THERAPEUTICS's median H-1B salary has increased by +51% from FY 2020 ($93,288) to FY 2025 ($140,795). Tracking salary trends over time reveals how VERVE THERAPEUTICS adjusts compensation to remain competitive in the H-1B labor market. Salary growth typically reflects inflation adjustments, increased demand for specialized skills, and evolving prevailing wage requirements. These historical trends can help applicants understand future salary expectations and negotiate appropriately when considering H-1B opportunities at VERVE THERAPEUTICS.

Year-by-year breakdown:

• FY 2021: $59,259 (1 certified)
• FY 2022: $90,000 (3 certified)
• FY 2023: $100,000 (9 certified)
• FY 2024: $122,000 (5 certified)
• FY 2025: $140,795 (4 certified)

This 51% growth reflects strong compensation adjustments at VERVE THERAPEUTICS, keeping pace with market demands for H-1B talent.

VERVE THERAPEUTICS primarily files H-1B applications at Wage Level I, accounting for 42% of their filings. DOL wage levels range from Level I (entry-level, 17th percentile of local wages) to Level IV (expert, 67th percentile). Wage level determines both salary requirements and, under recent H-1B rules, lottery selection priority. Higher wage levels receive preference in the H-1B lottery, making VERVE THERAPEUTICS's wage level distribution an important factor for prospective applicants assessing their chances of H-1B selection.

VERVE THERAPEUTICS has a mix of entry-level (Level I) and experienced (Level II+) H-1B positions. This reflects a range of roles from junior to senior.

VERVE THERAPEUTICS's median H-1B salary of $100,797 is 16% lower than the national H-1B median of $120,000 across all employers and industries. This comparison provides context for evaluating VERVE THERAPEUTICS's competitiveness in attracting H-1B talent. Keep in mind that industry, location, and job function significantly impact salary levels. Tech companies and financial institutions typically offer higher H-1B salaries than other sectors, while salaries in major metros like San Francisco and New York exceed those in smaller markets. Compare VERVE THERAPEUTICS's offerings with similar companies in your field for a more accurate assessment.

VERVE THERAPEUTICS's H-1B salaries are below the national median, though this may vary significantly by role, experience level, and location. Consider researching specific positions for more accurate compensation expectations.

Recent H-1B rule changes have increased filing fees and introduced wage-level prioritization in the lottery. VERVE THERAPEUTICS files 42% of positions at Level I, which may face more lottery competition under wage-level prioritization rules.

With 24 certified filings, VERVE THERAPEUTICS invests significantly in H-1B sponsorship. The company's 7.4% denial rate suggests room for improvement in H-1B application preparation.

Note: H-1B regulations are subject to change. Fees shown are estimates based on 2024 USCIS fee schedules. Actual costs may vary based on company size, premium processing, and future rule changes.